You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

B7-H3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

Not yet recruiting
  • Central Nervous System Neoplasms
  • +6 more
  • B7-H3-CAR T cells
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 18, 2023

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

Soluble B7-H3 as a Biomarker for Osteosarcoma

Recruiting
  • Biomarker
  • +3 more
  • ELISA: enzyme-linked immunosorbent assay
  • Beijing, Beijing, China
    Peking University People's Hospital
Jul 5, 2023

Recurrent Glioblastoma, Refractory Glioblastoma Trial in Hangzhou, Huzhou, Ningbo (Temozolomide, B7-H3 CAR-T)

Recruiting
  • Recurrent Glioblastoma
  • Refractory Glioblastoma
  • Hangzhou, Zhejiang, China
  • +2 more
Dec 25, 2022

Brain and Nervous System Trial in Palo Alto (B7-H3CART)

Recruiting
  • Brain and Nervous System
  • Palo Alto, California
    Stanford Cancer Institute
Jul 22, 2022

Advanced Glioma, Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy Trial in Suzhou (Targeted IL-13 Ra2 UCAR-T cell

Recruiting
  • Advanced Glioma
  • Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy
  • Targeted IL-13 Rα2 UCAR-T cell injection
  • Targeted B7-H3 UCAR-T cell injection
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Mar 2, 2023

Advanced Solid Tumor Trial in Lianyungang (KT095 CAR-T injection)

Not yet recruiting
  • Advanced Solid Tumor
  • KT095 CAR-T injection
  • Lianyungang, Jiangsu, China
    Lianyungang First People's Hospital
Aug 23, 2022

Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

Recruiting
  • Brain Gliomas
  • Allogenic B7H3 CAR-γδT cell
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023

B7-H3-positive Relapsed/ Refractory Neuroblastoma Trial in Tianjin (T cell injection targeting FLT3 chimeric antigen receptor)

Not yet recruiting
  • B7-H3-positive Relapsed/ Refractory Neuroblastoma
  • T cell injection targeting FLT3 chimeric antigen receptor
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Nov 1, 2022

Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jun 30, 2022

CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric

Recruiting
  • Central Nervous System Tumor
  • +10 more
  • SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
  • Seattle, Washington
    Seattle Children's Hospital
Dec 14, 2022

EGFR/ B7H3-positive Advanced Lung Cancer, EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer Trial in Guangzhou

Recruiting
  • EGFR/ B7H3-positive Advanced Lung Cancer
  • EGFR/ B7H3-positive Advanced Triple-negative Breast Cancer
  • EGFR/B7H3 CAR-T
  • Guangzhou, Guangdong, China
    Second Affiliated Hospital of Guangzhou Medical University
Apr 18, 2022

Glioblastoma Trial in Beijing (B7-H3-targeting CAR-T cells)

Recruiting
  • Glioblastoma
  • B7-H3-targeting CAR-T cells
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Feb 11, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

Not yet recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +4 more
  • SC-CAR4BRAIN
  • Seattle, Washington
    Seattle Children's Hospital
Mar 3, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • B7-H3 target, CAR gene modified gdT cell injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital， Zhejiang University School of Med
Feb 15, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • gdT cell injection targeting B7-H3 chimeric antigen receptor
  • Hefei, Anhui, China
    PersonGen Anke Cellular Therapeutice Co., Ltd.
Jan 31, 2023

Hepatocellular Carcinoma Trial in Xuzhou (fhB7H3.CAR-Ts, Fludarabine, Cyclophosphamide)

Recruiting
  • Hepatocellular Carcinoma
  • fhB7H3.CAR-Ts
  • +2 more
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Apr 5, 2022

The Role of B7-H4 in Tumor Vaccine

Recruiting
  • Glioma
  • tumor vaccine
  • Shanghai, Shanghai, China
    Di Chen
Nov 26, 2023

Lung Cancer, Cancer, Immunotherapy Trial in Guangzhou (CAR-T cells targeting PSCA, MUC1, TGFß, HER2, Mesothelin, Lewis-Y, GPC3,

Recruiting
  • Lung Cancer
  • +3 more
  • CAR-T cells targeting PSCA, MUC1, TGFβ, HER2, Mesothelin, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2, or B7-H3
  • Guangzhou, Guangdong, China
  • +1 more
Nov 26, 2021

Ovarian Cancer Trial in Xuzhou (fhB7H3.CAR-Ts)

Recruiting
  • Ovarian Cancer
  • fhB7H3.CAR-Ts
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jan 25, 2022

Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)

Completed
  • Neuroblastoma
  • +5 more
  • Palo Alto, California
  • +5 more
Feb 4, 2022

Locally Advanced/Metastatic Solid Tumours Trial (BAT8009 for Injection)

Recruiting
  • Locally Advanced/Metastatic Solid Tumours
  • BAT8009 for Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 25, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Bipolar Disorder Trial in Canada (Cannabidiol, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Calgary, Alberta, Canada
  • +7 more
May 18, 2023

Disease Activity in Canadian Adult Moderate-to-Severe Atopic

Recruiting
  • Atopic Dermatitis
    • Calgary, Alberta, Canada
    • +17 more
    Jan 17, 2023